These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11550331)

  • 1. [Octreotide (Famsynthesis): new possibilities in gastroenterology].
    Velichko MA; Vreshch VD
    Voen Med Zh; 2001 May; 322(5):44-5. PubMed ID: 11550331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prokinetic medication in gastroenterology].
    Lachter J; Eidelman S
    Harefuah; 1998 Apr; 134(7):553-7. PubMed ID: 10909602
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sandostatin treatment of destructive pancreatitis].
    Ivanov IuV
    Klin Med (Mosk); 1999; 77(9):37-9. PubMed ID: 10599225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The potentials for using sandostatin in gastroenterology (a review)].
    Lopatkina TN
    Ter Arkh; 1995; 67(7):66-8. PubMed ID: 7482311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications for the use of somatostatin and octreotide in digestive pathology].
    Zan S; Roy L; Zanon C; Mobiglia A; Mussa B; Raviola P; Mormile C; Ballario R; Giustetto A
    Minerva Gastroenterol Dietol; 1996 Jun; 42(2):107-14. PubMed ID: 8962905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in pediatric patients.
    Heikenen JB; Pohl JF; Werlin SL; Bucuvalas JC
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):600-9. PubMed ID: 12454572
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives in gastroenterology. Proceedings of Somatostatin Analogues--Peptide Therapy in Action Symposium. January 10th, 1989, London.
    Digestion; 1990; 45 Suppl 1():45-87. PubMed ID: 2335267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postoperative treatment of acute pancreatitis].
    Agaev BA; Mamedova NA
    Khirurgiia (Mosk); 2009; (8):73-6. PubMed ID: 19798777
    [No Abstract]   [Full Text] [Related]  

  • 9. [Octreotide in the treatment of gastrointestinal disorders].
    Jorquera Plaza F; Culebras Fernández JM
    Nutr Hosp; 1996; 11(4):213-4. PubMed ID: 8962900
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapeutic applications of octreotide].
    Carrera-Hueso FJ; Carrera-Hueso JA; Llorente I
    Med Clin (Barc); 1996 Apr; 106(13):505-16. PubMed ID: 8992134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of somatostatin receptor of pancreas and effectiveness of octreotide on acute necrotizng pancreatitis in mice].
    Wu J; Yuan Y; Xu J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(12):740-3. PubMed ID: 11798959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of major gastroenterologic diseases].
    Ryss ES; Fishzon-Ryss IuI
    Sov Med; 1989; (11):37-41. PubMed ID: 2626707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
    Dhar A; Chawla YK
    Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure.
    Fiedler F; Jauernig G; Keim V; Richter A; Bender HJ
    Intensive Care Med; 1996 Sep; 22(9):909-15. PubMed ID: 8905425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current aspects of sandostatin use in gastroenterology and surgery (review of literature for 1993-1998)].
    Ivanov IuV; Dubinin VIu; Ivanov VV; Alekhnovich AV
    Ter Arkh; 1999; 71(8):78-80. PubMed ID: 10515044
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of gut peptide receptor agonists and antagonists in gastrointestinal diseases.
    Maton PN; Jensen RT
    Gastroenterol Clin North Am; 1992 Sep; 21(3):551-66. PubMed ID: 1355466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis.
    Andriulli A; Loperfido S
    Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.